Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Udo Jeschke

Showing results (271-280 of 401) with videos related to

Pageof 41
Sort By:
Journal of Cancer Research and Clinical Oncology|September 6, 2019
EP3 receptor is a prognostic factor in TA-MUC1-negative ovarian cancerBastian Czogalla, Christina Kuhn, Sabine Heublein, et al.
Journal of Cancer Research and Clinical Oncology|June 4, 2021
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancerWanting Shao, Christina Kuhn, Doris Mayr, et al.
Cell Death Discovery|June 5, 2026
Identification of tumor-promoting functions of the Homeobox family transcription factor MSX1 in cervical cancerPaulina Brücker, Svenja Horn, Shaishavi Jansari, et al.
Histology and Histopathology|January 1, 2013
Staining of MUC1 in ovarian cancer tissues with PankoMab-GEX detecting the tumour-associated epitope, TA-MUC1, as compared to antibodies HMFG-1 and 115D8Darius Dian, Miriam Lenhard, Doris Mayr, et al.
Journal of Cancer Research and Clinical Oncology|January 23, 2023
MTA1 as negative prognostic marker in vulvar carcinomaGiulia Wanka, Julia Jueckstock, Carl Mathis Wild, et al.
International Journal of Molecular Sciences|March 10, 2022
Subcellular Distribution of Thyroid Hormone Receptor Beta in Ovarian CancerSabine Heublein, Udo Jeschke, Cornelia Sattler, et al.
Cells|April 3, 2021
The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In VitroNan Han, Sabine Heublein, Udo Jeschke, et al.
BMC Research Notes|July 26, 2012
Influence of maternal age, gestational age and fetal gender on expression of immune mediators in amniotic fluidTobias Weissenbacher, Rüdiger P Laubender, Steven S Witkin, et al.
Journal of Cancer Research and Clinical Oncology|July 30, 2020
Lysine-specific histone demethylase 1A (LSD1) in cervical cancerDaniel Beilner, Christina Kuhn, Bernd P Kost, et al.
Journal of Cancer Research and Clinical Oncology|June 4, 2020
Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR)Yao Ye, Lin Peng, Aurelia Vattai, et al.
Pageof 41

Showing results (271-280 of 401) with videos related to

Sort By:
Pageof 41
Journal of Cancer Research and Clinical Oncology|September 6, 2019
EP3 receptor is a prognostic factor in TA-MUC1-negative ovarian cancerBastian Czogalla, Christina Kuhn, Sabine Heublein, et al.
Journal of Cancer Research and Clinical Oncology|June 4, 2021
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancerWanting Shao, Christina Kuhn, Doris Mayr, et al.
Cell Death Discovery|June 5, 2026
Identification of tumor-promoting functions of the Homeobox family transcription factor MSX1 in cervical cancerPaulina Brücker, Svenja Horn, Shaishavi Jansari, et al.
Histology and Histopathology|January 1, 2013
Staining of MUC1 in ovarian cancer tissues with PankoMab-GEX detecting the tumour-associated epitope, TA-MUC1, as compared to antibodies HMFG-1 and 115D8Darius Dian, Miriam Lenhard, Doris Mayr, et al.
Journal of Cancer Research and Clinical Oncology|January 23, 2023
MTA1 as negative prognostic marker in vulvar carcinomaGiulia Wanka, Julia Jueckstock, Carl Mathis Wild, et al.
International Journal of Molecular Sciences|March 10, 2022
Subcellular Distribution of Thyroid Hormone Receptor Beta in Ovarian CancerSabine Heublein, Udo Jeschke, Cornelia Sattler, et al.
Cells|April 3, 2021
The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In VitroNan Han, Sabine Heublein, Udo Jeschke, et al.
BMC Research Notes|July 26, 2012
Influence of maternal age, gestational age and fetal gender on expression of immune mediators in amniotic fluidTobias Weissenbacher, Rüdiger P Laubender, Steven S Witkin, et al.
Journal of Cancer Research and Clinical Oncology|July 30, 2020
Lysine-specific histone demethylase 1A (LSD1) in cervical cancerDaniel Beilner, Christina Kuhn, Bernd P Kost, et al.
Journal of Cancer Research and Clinical Oncology|June 4, 2020
Prostaglandin E2 receptor 3 (EP3) signaling promotes migration of cervical cancer via urokinase-type plasminogen activator receptor (uPAR)Yao Ye, Lin Peng, Aurelia Vattai, et al.
Pageof 41